Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Gerber Foundation | OTHER |
Not provided
Not provided
Not provided
Not provided
This is a prospective crossover study to compare the within-subject effect of the two target ranges of arterial oxygen saturation (SpO2), both within the clinically recommended range of 90- 95%. The specific objective of this study to evaluate the impact of targeting SpO2 within 93-95% compared to the 90-92% range on ventilatory stability in premature infants of 23-29 weeks gestational age (GA).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Targeting SpO2 at 93-95% followed by targeting at 90-92% | Other | FiO2 adjusted to keep basal SpO2 at target range of 93-95% for 2 hours, followed by FiO2 adjusted to keep basal SpO2 at target range of 90-92% for 2 hours. |
|
| Targeting SpO2 at 90-92% followed by targeting at 93-95% | Other | FiO2 adjusted to keep basal SpO2 at target range of 90-92% for 2 hours, followed by FiO2 adjusted to keep basal SpO2 at target range of 93-95% for 2 hours. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Targeting SpO2 at 93-95% | Other | FiO2 adjusted to keep basal SpO2 at target range of 93-95% for 2 hours |
|
| Measure | Description | Time Frame |
|---|---|---|
| ventilatory stability by frequency of central apnea | by frequency of central apnea | 2 hours |
| ventilatory stability by frequency of obstructive apnea | by frequency of obstructive apnea | 2 hours |
| ventilatory stability by density of periodic breathing | by density of periodic breathing | 2 hours |
| ventilatory stability by time series of inter-breath intervals | by time series of inter-breath intervals | 2 hours |
| Measure | Description | Time Frame |
|---|---|---|
| oxygenation stability by frequency of intermittent hypoxemia episodes | frequency of episodes with SpO2 < 80% | 2 hours |
| frequency of bradycardia episodes | frequency of episodes with HR < 100 bpm |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nelson Claure, MSc, PhD | University of Miami | Principal Investigator |
| Eduardo Bancalari, MD | University of Miami | Principal Investigator |
| Deepak Jain, MD | University of Miami | Principal Investigator |
| Waleed Kurtom, MD | Jackson Health System | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Holtz Children's Hospital | Miami | Florida | 33136 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36030769 | Derived | Kurtom W, Dormishian A, Jain D, Schott A, Aguilar AC, Grieb G, Bancalari E, Claure N. Effect of the Target Range on Arterial Oxygen Saturation Stability in Extremely Premature Infants. Neonatology. 2022;119(5):638-643. doi: 10.1159/000525271. Epub 2022 Aug 26. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001049 | Apnea |
| D020182 | Sleep Apnea, Central |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
Not provided
Not provided
This is a prospective crossover study to compare the within-subject effect of the two target ranges of arterial oxygen saturation (SpO2, 93-95% vs 90-92%) on ventilatory stability in premature infants.
Not provided
Not provided
Not provided
Not provided
| Targeting SpO2 at 90-92% | Other | FiO2 adjusted to keep basal SpO2 at target range of 90-92% for 2 hours. |
|
| 2 hours |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012891 | Sleep Apnea Syndromes |
| D020919 | Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |